PERSONIFICATION OF ANTIHYPERTENSIVE THERAPY IN ISCHEMIC CEREBRAL STROKE.

The purpose of the study is to optimize monitoring and personalize antihypertensive therapy in patients with severe ischemic cerebral stroke (ICS). We examined 37 patients with ICS, average age 74,1±1,3 years, who received treatment in intensive care wards of the stroke department with general neurology beds of the Municipal Non-Profit Enterprise "City Hospital № 9" of the Zaporizhzhia City Council. There were 16 men (43,2%), average age 71,9±2,1 years; women - 21 (56,8%), average age 75,8±1.

[INTEGRATIVE MONITORING FOR INTRACEREBRAL COMPLICATIONS OF ISCHEMIC STROKE].

The severity of neurological deficit according to the NIHSS scale, for critical patients with an intracerebral complications of ischemic stroke (ICIS), corresponded to severe ischemic stroke in both the group of surviving patients (15,5±0,4 points) and the group of deceased patients from ICIS (16,1±0,6 points). At a time when the predictors of an unfavorable result of 21 critical patients with an ICIS were cerebral perfusion pressure <50 mm Hg. (p<0,05), cardiac index ˂1,8 L×min-1×m-2 (p<0,05), oxygen delivery index ˂280 mL×min-1×m-2 (p<0,05), plasma osmolality > 325 mmol×L-1 (p<0,05), progression of diastolic destabilization > 20% (p<0,05).